Published Date:2022-12-21 Original Link:https://www.onenessbio.com/en/news_detail192_1.htm No 1 Date of announcement 2022/12/21 Time of announcement 17:12:56 Subject Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology. To which item it meets paragraph 12 Date of events 2022/12/28 Statement Date of institutional investor conference:2022/12/28 Time of institutional investor conference:15:00...Read More

Published Date:2022-12-20 Original Link:https://www.onenessbio.com/en/news_detail190_1.htm No 1 Date of announcement 2022/12/20 Time of announcement 17:00:32 Subject  Oneness Biotech Co., Ltd. receives a Malaysian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2022/12/20 Statement Date of occurrence of the event:2022/12/20 Company...Read More

Published Date:2022-12-20 Original Link:https://www.onenessbio.com/en/news_detail191_1.htm No 2 Date of announcement 2022/12/20 Time of announcement 17:16:40 Subject Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology. To which item it meets paragraph 53 Date of events 2022/12/20 Statement Date of occurrence of the event:2022/12/20 Company name:ONENESS BIOTECH CO.,...Read More

Published Date:2022-12-06 Original Link:https://www.onenessbio.com/en/news_detail189_1.htm No 1 Date of announcement 2022/12/06 Time of announcement 17:07:51 Subject Oneness has been invited for a poster presentation with on-site Q&A for the Phase 3 MRCT post-hoc analysis of the DFU new drug, Fespixon at IDF Congress 2022. To which item it meets paragraph 12 Date of events 2022/12/07 Statement...Read More

Published Date:2022-12-02 Original Link:https://www.onenessbio.com/en/news_detail188_1.htm No 1 Date of announcement 2022/12/02 Time of announcement 20:03:27 Subject The post-market hard-to-heal cases treated by the DFU new drug, Fespixon have been accepted for an oral presentation at 2022 CDS To which item it meets paragraph 12 Date of events 2022/12/04 Statement Date of institutional investor conference:2022/12/04 Time of...Read More

Published Date:2022-11-29 Original Link:https://www.onenessbio.com/en/news_detail185_1.htm No 1 Date of announcement 2022/11/29 Time of announcement 15:27:42 Subject The trading of Oneness securities in centralized securities exchange market follows Announcement or Notice of Attention to Trading Information To which item it meets paragraph 53 Date of events 2022/11/29 Statement Date of occurrence of the event:2022/11/29 Cause of occurrence:Proceeded...Read More

Published Date:2022-11-09 Original Link:https://www.onenessbio.com/en/news_detail183_1.htm No 3 Date of announcement 2022/11/09 Time of announcement 16:48:49 Subject The Board of Directors of Oneness has approved a donation to Teh-Tzer Study Group for Human Medical Research Foundation. To which item it meets paragraph 43 Date of events 2022/11/09 Statement Date of occurrence of the event:2022/11/09 Reason for the...Read More

Published Date:2022-11-09 Original Link:https://www.onenessbio.com/en/news_detail181_1.htm No 1 Date of announcement 2022/11/09 Time of announcement 16:11:18 Subject The Company’s 2022Q3 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2022/11/09 Statement Date of the board of directors submitted or approved:2022/11/09 Date of the audit committee...Read More

Published Date:2022-11-09 Original Link:https://www.onenessbio.com/en/news_detail182_1.htm No 2 Date of announcement 2022/11/09 Time of announcement  16:45:58 Subject Annouce the change of the corporate governance officer. To which item it meets paragraph 8 Date of events 2022/11/09 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate...Read More

Published Date:2022-10-27 Original Link:https://www.onenessbio.com/en/news_detail180_1.htm No 1 Date of announcement 2022/10/27 Time of announcement  17:02:31 Subject Oneness Biotech Co., Ltd. receives Israeli, Mexican and Hong Kong patents on the producing recombinant glycoproteins with modified glycosylation. To which item it meets paragraph 53 Date of events 2022/10/27 Statement Date of occurrence of the event: 111/10/27 Company name:...Read More